Komori
Occurring Fact4263SUSMED,Inc.Information and Communications, Services and Others

Summary of Financial Results for the First Quarter of the Fiscal Year Ending June 2027 [Japanese GAAP] (Non-consolidated)

During the first quarter of the fiscal year ending June 2027, the Company recognized an impairment loss of ¥141.341 million on company-wide assets at its head office (building improvements, tools, furniture and fixtures) as an extraordinary loss. Although the quarterly net loss was ¥203.339 million, the full-year earnings forecast remains unchanged.

Worth reading
52Recurring
Scored from 4 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
141341
Thousand yen
Wording
Conditional
How definitive the wording is.

Impairment loss recognized on company-wide assets

Subject Entity

SUSMED,Inc. (the Company)

Target Locations / Products

Head office, company-wide assets (building improvements, tools, furniture and fixtures)

OccurrenceDuring the cumulative first-quarter period from 1 July 2026 to 30 September 2026 (specific date of occurrence: Not disclosed)
This disclosure11/06/2026
Cause

Because operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below the carrying amount.

Amount of Impact on Business Performance

¥141.341 million (impairment loss recognized as an extraordinary loss)

Accounting period in which recognized

Cumulative first quarter of the fiscal year ending June 2027 (from 1 July 2026 to 30 September 2026)

Impact on Earnings Forecast

No change to the earnings forecast for the fiscal year ending June 2027

Outlook

The earnings forecast for the fiscal year ending June 2027 will not be changed. Actual results may differ materially from the forecast figures due to various factors.

Event that occurred
ItemDetails
Event nameImpairment loss recognized on company-wide assets
Date of occurrenceDuring the cumulative first-quarter period from 1 July 2026 to 30 September 2026 (specific date of occurrence: Not disclosed)
Subject EntitySUSMED,Inc. (the Company)
Target Locations / ProductsHead office, company-wide assets (building improvements, tools, furniture and fixtures)
CauseBecause operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below the carrying amount.
Amount of Impact on Business Performance¥141.341 million (impairment loss recognized as an extraordinary loss)
Accounting period in which recognizedCumulative first quarter of the fiscal year ending June 2027 (from 1 July 2026 to 30 September 2026)
Impact on Earnings ForecastNo change to the earnings forecast for the fiscal year ending June 2027
OutlookThe earnings forecast for the fiscal year ending June 2027 will not be changed. Actual results may differ materially from the forecast figures due to various factors.
Items this document does not state (16)
Date recognized / date notice receivedType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because operating cash flow has remained negative and total undiscounted future cash flows are expected to fall below the carrying amount, the carrying amount was reduced to the recoverable amount.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the First Quarter of the Fiscal Year Ending June 2027 [Japanese GAAP] (Non-consolidated) | SUSMED,Inc. (4263) timely disclosure | Komori